ALAN WILLS Insider Trading $AUXL AUXILIUM PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ALAN WILLS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ALAN WILLS. ALAN WILLS is EVP, Corporate Development in AUXILIUM PHARMACEUTICALS INC ($AUXL).
ALAN WILLS in AUXILIUM PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ALAN WILLS: EVP, Corporate Development
Holdings: 0 shares
Latest Transaction: Jan 30 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ALAN WILLS in AUXILIUM PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 30 2015 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Option Exercise | J | 28.30 | 35,000 | 990,500 | 0 | |
| Jan 30 2015 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Option Exercise | J | 18.30 | 28,125 | 514,688 | 0 | |
| Jan 30 2015 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Option Exercise | J | 19.51 | 28,500 | 556,035 | 0 | |
| Jan 30 2015 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Option Exercise | J | 22.04 | 10,000 | 220,400 | 0 | |
| Jan 30 2015 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Sell | J | 36.53 | 30,743 | 1,123,042 | 0 | 30.7 K to 0 (-100.00 %) |
| Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Option Exercise | M | 18.30 | 9,375 | 171,563 | 28,125 | |
| Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Option Exercise | M | 19.51 | 28,500 | 556,035 | 28,500 | |
| Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Option Exercise | M | 22.04 | 30,000 | 661,200 | 10,000 | |
| Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Option Exercise | M | 25.90 | 75,000 | 1,942,500 | 0 | |
| Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Sell | S | 33.18 | 13,717 | 455,086 | 30,743 | 44.5 K to 30.7 K (-30.85 %) |
| Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Sell | S | 33.18 | 142,875 | 4,740,207 | 44,460 | 187.3 K to 44.5 K (-76.27 %) |
| Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Buy | M | 18.30 | 9,375 | 171,563 | 187,335 | 178 K to 187.3 K (+5.27 %) |
| Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Buy | M | 19.51 | 28,500 | 556,035 | 177,960 | 149.5 K to 178 K (+19.07 %) |
| Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Buy | M | 22.04 | 30,000 | 661,200 | 149,460 | 119.5 K to 149.5 K (+25.11 %) |
| Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Buy | M | 25.90 | 75,000 | 1,942,500 | 119,460 | 44.5 K to 119.5 K (+168.69 %) |
| Oct 27 2014 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Payment of Exercise | F | 31.34 | 836 | 26,200 | 44,460 | 45.3 K to 44.5 K (-1.85 %) |
| Jun 23 2014 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Payment of Exercise | F | 21.18 | 168 | 3,558 | 45,296 | 45.5 K to 45.3 K (-0.37 %) |
| Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Option Exercise | A | 0.00 | 24,000 | 0 | 24,000 | |
| Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Option Exercise | A | 28.30 | 35,000 | 990,500 | 35,000 | |
| Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Grant | A | 0.00 | 14,500 | 0 | 45,464 | 31 K to 45.5 K (+46.83 %) |
| Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Payment of Exercise | F | 28.30 | 704 | 19,923 | 30,964 | 31.7 K to 31 K (-2.22 %) |
| Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Grant | A | 0.00 | 6,375 | 0 | 31,668 | 25.3 K to 31.7 K (+25.20 %) |
| Feb 11 2014 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Payment of Exercise | F | 23.68 | 2,269 | 53,730 | 25,293 | 27.6 K to 25.3 K (-8.23 %) |
| Oct 29 2013 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Payment of Exercise | F | 17.27 | 813 | 14,041 | 27,562 | 28.4 K to 27.6 K (-2.87 %) |
| Jun 25 2013 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Payment of Exercise | F | 17.15 | 187 | 3,207 | 28,375 | 28.6 K to 28.4 K (-0.65 %) |
| Feb 11 2013 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Option Exercise | A | 18.30 | 37,500 | 686,250 | 37,500 | |
| Feb 11 2013 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Payment of Exercise | F | 18.30 | 426 | 7,796 | 28,562 | 29 K to 28.6 K (-1.47 %) |
| Feb 11 2013 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Grant | A | 0.00 | 15,200 | 0 | 28,988 | 13.8 K to 29 K (+110.24 %) |
| Feb 11 2013 | AUXL | AUXILIUM PHARMACEU ... | WILLS ALAN | EVP, Corporate Deve ... | Grant | A | 0.00 | 3,940 | 0 | 13,788 | 9.8 K to 13.8 K (+40.01 %) |
Page: 1